A Clinical study of Shalmalyadi ghrita orally and Shalmalyadi ghrita Pichu in the patients of Asrigdara.
Phase 2
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2023/09/057997
- Lead Sponsor
- State Ayurvedic college and Hospital Lucknow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult married female who are in age group of 20-45years.
2.Patient willing for trial.
3.Patients simultaneously diagnosed with cardinal symptoms of Asrigdara / DUB (Excessive, prolonged and intermenstrual bleeding) .
Exclusion Criteria
1.Patients below 20 yrs and above 45 yrs.
2.Patients with Post menopausal bleeding
3.Patients with Hb less than 8 %
4.Patient with any other pelvic pathology(chronic cervicitis , fibroid and malignancy)
5.Patient on oral contraceptives, or using intrauterine contraceptive devices.
6.Patients with systemic diseases (diabetes mellitus, tuberculosis, jaundice, severe HTN).
7.VDRL, HIV, HBsAg positive patient.
8.Patients having coagulation disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To assess the efficacy of trial therapy on subjective parameters like Amount of menstrual bleeding, Duration of Menstrual cycle, Interval of Menstrual cycle , Passage of clots during menstruation, Pain during menstruation. <br/ ><br>Timepoint: 2 months
- Secondary Outcome Measures
Name Time Method 1.To assess the efficacy of trial therapy on subjective parameters like Amount of menstrual bleeding, Duration of Menstrual cycle, Interval of Menstrual cycle , Passage of clots during menstruation, Pain during menstruation. <br/ ><br>Timepoint: Follow up - On the clearance of each menstrual <br/ ><br>cycle during the period of treatment.